DD209458A5 - Verfahren zur herstellung eines durch eine arylgruppe substituierten mutterkornalkaloids und seiner saeureadditionssalze - Google Patents

Verfahren zur herstellung eines durch eine arylgruppe substituierten mutterkornalkaloids und seiner saeureadditionssalze Download PDF

Info

Publication number
DD209458A5
DD209458A5 DD83248035A DD24803583A DD209458A5 DD 209458 A5 DD209458 A5 DD 209458A5 DD 83248035 A DD83248035 A DD 83248035A DD 24803583 A DD24803583 A DD 24803583A DD 209458 A5 DD209458 A5 DD 209458A5
Authority
DD
German Democratic Republic
Prior art keywords
hydrogen
compounds
aryl group
formula
carboxy
Prior art date
Application number
DD83248035A
Other languages
German (de)
English (en)
Inventor
Georg Bolliger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DD209458A5 publication Critical patent/DD209458A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD83248035A 1982-02-17 1983-02-17 Verfahren zur herstellung eines durch eine arylgruppe substituierten mutterkornalkaloids und seiner saeureadditionssalze DD209458A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH98782 1982-02-17

Publications (1)

Publication Number Publication Date
DD209458A5 true DD209458A5 (de) 1984-05-09

Family

ID=4199836

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83248035A DD209458A5 (de) 1982-02-17 1983-02-17 Verfahren zur herstellung eines durch eine arylgruppe substituierten mutterkornalkaloids und seiner saeureadditionssalze

Country Status (19)

Country Link
JP (1) JPS58152884A (cs)
AU (1) AU1142083A (cs)
BE (1) BE895898A (cs)
CS (1) CS236786B2 (cs)
DD (1) DD209458A5 (cs)
DE (1) DE3304361A1 (cs)
DK (1) DK66483A (cs)
ES (1) ES8407060A1 (cs)
FI (1) FI830462L (cs)
FR (1) FR2521562B1 (cs)
GB (1) GB2115811B (cs)
GR (1) GR79562B (cs)
IT (1) IT1197578B (cs)
NL (1) NL8300558A (cs)
NO (1) NO830482L (cs)
PL (1) PL240608A1 (cs)
PT (1) PT76242B (cs)
SE (1) SE8300865L (cs)
ZA (1) ZA831089B (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734501A (en) * 1985-10-01 1988-03-29 Eli Lilly And Company N-alkylation of dihydrolysergic acid
GB0808326D0 (en) * 2008-05-08 2008-06-18 E Therapeutics Plc Compositions and methods for the treatment of fybromyalgia

Also Published As

Publication number Publication date
GB2115811A (en) 1983-09-14
CS236786B2 (en) 1985-05-15
IT1197578B (it) 1988-12-06
DK66483D0 (da) 1983-02-15
PT76242A (en) 1983-03-01
FI830462A7 (fi) 1983-08-18
NL8300558A (nl) 1983-09-16
PL240608A1 (en) 1984-10-08
GB2115811B (en) 1985-08-14
ZA831089B (en) 1984-09-26
SE8300865D0 (sv) 1983-02-16
FR2521562A1 (fr) 1983-08-19
PT76242B (en) 1986-01-10
SE8300865L (sv) 1983-08-18
ES519811A0 (es) 1984-08-16
IT8347734A0 (it) 1983-02-17
FR2521562B1 (fr) 1985-10-25
DK66483A (da) 1983-08-18
FI830462A0 (fi) 1983-02-10
GB8304011D0 (en) 1983-03-16
DE3304361A1 (de) 1983-08-25
JPS58152884A (ja) 1983-09-10
BE895898A (fr) 1983-08-16
ES8407060A1 (es) 1984-08-16
NO830482L (no) 1983-08-18
AU1142083A (en) 1983-08-25
GR79562B (cs) 1984-10-30
FI830462L (fi) 1983-08-18

Similar Documents

Publication Publication Date Title
DE69106365T2 (de) Chinuclidinderivate.
DE69223989T2 (de) Azyklische ethylendiaminderivate als 'substance p rezeptor' antagonisten
EP0418716B1 (de) Neue Thienylcarbonsäureester von Aminoalkoholen, ihre Quaternierungsprodukte sowie die Herstellung und Verwendung dieser Verbindungen
DE69305276T2 (de) Arylglycinamidderivate, Verfahren zur deren Herstellung und deren Verwendung zur Therapie der Dysurie
DE9290042U1 (de) Pro-Arzneimittelester von phenolischen 2-Piperidino-1-alkanolen
DE2524054A1 (de) 1-cycloalkylmethyl-3a-(substituiertes-phenyl)-decahydroisochinoline
DE2524053A1 (de) 1-aethyl-3a-substituiertes-phenyl- decahydroisochinoline
CH617934A5 (cs)
EP0546389B1 (de) Piperidylmethyl substituierte Chromanderivate als Wirkstoffe zur Behandlung von Erkrankungen des Zentralnervensystems
DE69007900T2 (de) 4,4-Disubstituierte Piperidinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DE2658558A1 (de) Diazabicyclo(3,3,1)nonane, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE4131584A1 (de) Imidazolylmethyl-pyridine, ihre herstellung und anwendung als pharmazeutika
DD209458A5 (de) Verfahren zur herstellung eines durch eine arylgruppe substituierten mutterkornalkaloids und seiner saeureadditionssalze
EP0234516A1 (de) 1,6-Naphthyridin-Derivate,Verfahren zu deren Herstellung und diese enthaltende Arzneimittel zur Behandlung von Gefässerkrankungen
DE2748466A1 (de) 4a-aryloctahydro-1h-2-pyrindine
DE1816993A1 (de) Verfahren zur Herstellung von 1-Aoyl- oder 1-Heteroaroyl- oder 1-Benzheteroaroyl-2-methyl-5-alkoxy-(oder 5-aralkoxy)-indolyl-3-essigsaeuren
DE2845857A1 (de) Benzo eckige klammer auf d eckige klammer zu thiazolderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittelzubereitungen
DE69006973T2 (de) 2-Oxo-1-oxa-8-azaspiro[4,5]decanderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
DE69804853T2 (de) Verfahren zur herstellung von mequitazin und zwischenprodukt der synthese
EP0717043B1 (de) Verwendung von 1,2-überbrückten 1,4-Dihydropyridinen als selektive Kaliumkanalmodulatoren
DE2626583A1 (de) Neue benzocycloheptathiophenderivate ihre herstellung und ihre verwendung als heilmittel
DE2331721A1 (de) Verfahren zur herstellung neuer heterocyclischer verbindungen
EP0657432B1 (de) Phenyl-substituierte 1,4-Dihydropyridine mit cerebraler Aktivität
FR2703048A1 (fr) Nouveaux composés N-Benzylpiperazine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
DE1670152C2 (de) N-substituierte Granatanol-tropasäureester und ein Verfahren zu ihrer Herstellung